Patent ID: 8871758

Claim:
A compound of the formula I in which L is R1, —CH(R10)(R11); R10, R11 are each independently H, F, Cl, Br, I, OH, CF 3 , CHF 2 , CH 2 F, NO 2 , CN, OCF 3 , OCHF 2 , O—(C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyl, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , COOH, COO—(C 1 -C 6 )-alkyl, CONH 2 , CONH(C 1 -C 6 )-alkyl, CON((C 1 -C 6 )-alkyl) 2 , SF 5 , (C 1 -C 6 )-alkylene-(R6), (C 3 -C 8 )-cycloalkylene-(R6), (C 1 -C 6 )-alkylene-(C 3 -C 8 )-cycloalkylene-(R6), (C 6 -C 10 )-aryl, (C 1 -C 6 )-alkylene-(C 6 -C 10 )-aryl, —(C 6 -C 10 )-heteroaryl, (C 1 -C 6 )-alkylene-(C 6 -C 10 )-heteroaryl; where the aryl radical or heteroaryl radical may be mono- to trisubstituted by F, Cl, Br, I, OH, CF 3 , CHF 2 , CH 2 F, NO 2 , CN, OCF 3 , OCHF 2 , O—(C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyl, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , SO 2 —CH 3 , SO 2 —NH 2 , SO 2 —NH(C 1 -C 6 )-alkyl, SO 2 —N((C 1 -C 6 )-alkyl) 2 , COOH, COO—(C 1 -C 6 )-alkyl, CONH 2 , CONH(C 1 -C 6 )-alkyl, CON(C 1 -C 6 )-alkyl) 2 , SF 5 ; R6 is OH, CF 3 , CHF 2 , CH 2 F, NO 2 , CN, OCF 3 , OCHF 2 , O—(C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyl, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , SO 2 —CH 3 , SO 2 —NH 2 , SO 2 —NH(C 1 -C 6 )-alkyl, SO 2 —N((C 1 -C 6 )-alkyl) 2 , COOH, COO—(C 1 -C 6 )-alkyl, CONH 2 , CONH(C 1 -C 6 )-alkyl, CON((C 1 -C 6 )-alkyl) 2 , SF 5 ; R1 is (C 6 -C 10 )-aryl, (C 3 -C 8 )-cycloalkyl, (C 3 -C 8 )-carbocyclyl, where the aryl radical, cycloalkyl radical or carbocyclyl radical may be mono- to trisubstituted by F, Cl, Br, I, OH, CF 3 , CHF 2 , CH 2 F, NO 2 , CN, OCF 3 , OCHF 2 , O—(C 1 -C 6 )-alkyl, (C 1 -C 6 )-alkyl, NH 2 , NH(C 1 -C 6 )-alkyl, N((C 1 -C 6 )-alkyl) 2 , SO 2 —CH 3 , SO 2 —NH 2 , SO 2 —NH(C 1 -C 6 )-alkyl, SO 2 —N((C 1 -C 6 )-alkyl) 2 , COOH, COO—(C 1 -C 6 )-alkyl, CONH 2 , CONH(C 1 -C 6 )-alkyl, CON((C 1 -C 6 )-alkyl) 2 , SF 5 ; R2, R3, R4, R5 are each independently (C 1 -C 6 )-alkyl, CF 3 , CHF 2 , CH 2 F, (C 1 -C 6 )-alkylene-OH, (C 1 -C 6 )-alkylene-O—(C 1 -C 6 )-alkyl, or R2 and R3, or R4 and R5, together with the carbon atom to which they are bonded form a 3-8-membered saturated carbocyclic or heterocyclic ring which may contain up to 2 further heteroatoms from the group of N, O and S; and pharmaceutically acceptable salts thereof.